 previous article in this issue | next article in this issue  |
|
Document Details : Title: Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders Author(s): THOMEER M, DEMEDTS M, VANDEURZEN K, AND THE VRGT WORKING GROUP ON INTERSTITIAL LUNG DISEASES Journal: Acta Clinica Belgica Volume: 56 Issue: 3 Date: 2001 Pages: 163-172 DOI: 10.2143/ACB.56.3.1002846 Abstract : We report the results of a prospective registration of the prevalence of interstitial lung diseases by 20 centres of respiratory medicine in Flanders from January 1992 till July 1996. The 20 centres registered a total of 362 cases. Sarcoidosis (31% with inclusion of stage I, or 22% without stage I), idiopathic pulmonary fibrosis (20%), hypersensitivity pneumonitis (13%) and unclassified forms of interstitial lung diseases (9%) were the most often diagnosed diseases. The mean age of the patients was 52 ± 17 (SD) years, but ranged from 32 ± 10 years in histiocytosis X to 70 ± 13 years in drug induced interstitial lung diseases. The male to female ratio was 1.3 but ranged from 2.3 in interstitial lung diseases due to inhalation of inorganic materials to 0.8 in interstitial lung diseases due to connective tissue disease. The diagnosis was considered certain in 60%, probable in 30% and possible in 10%. In 50% of the cases the diagnosis was proven by biopsy and the most often used biopsy technique was transbronchiolo-alveolar biopsy (40% of biopsies) followed by open lung biopsy (32%). At diagnosis vital capacity was 82±22% pred. (ranging from 92±19% in sarcoidosis to 71±24% in idiopathic pulmonary fibrosis) and CO-diffusing capacity was 77±19% pred. (ranging from 77±19% in sarcoidosis to 41±13% in drug induced pneumonitis). The regional frequency of interstitial lung diseases in Flanders varied widely and was not proportional to the regional distribution of the 20 contributing centres. In conclusion this registration provides interesting information on the occurrence and presentation of the different forms of interstitial lung diseases, although it may still underestimate the real prevalence and incidence of interstitial lung diseases. |
